SGLT2 inhibitors: diabetic kidney disease and beyond

被引：2
|
作者：
Staruschenko, Alexander [1 ,2 ]
Bhalla, Vivek [3 ]
Rangaswami, Janani [4 ,5 ]
机构：
[1] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[2] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53295 USA
[3] Stanford Univ, Dept Med, Div Nephrol, Sch Med, Stanford, CA 94305 USA
[4] Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA
[5] Thomas Jefferson Univ, Sidney Kimmel Coll, Philadelphia, PA 19107 USA
来源：
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 2020年 / 319卷 / 05期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1152/ajprenal.00518.2020
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：F780 / F781
页数：2
相关论文
共 50 条
  • [1] SGLT2 Inhibitors in Diabetic Kidney Disease
    Zoungas, Sophia
    de Boer, Ian H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (04): : 631 - 633
  • [2] SGLT2 inhibitors to prevent diabetic kidney disease
    Fioretto, Paola
    Vettor, Roberto
    Pontremoli, Roberto
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (01): : 4 - 5
  • [3] SGLT2 Inhibitors and the Diabetic Kidney
    Fioretto, Paola
    Zambon, Alberto
    Rossato, Marco
    Busetto, Luca
    Vettor, Roberto
    [J]. DIABETES CARE, 2016, 39 : S165 - S171
  • [4] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    DeFronzo, Ralph A.
    Reeves, W. Brian
    Awad, Alaa S.
    [J]. NATURE REVIEWS NEPHROLOGY, 2021, 17 (05) : 319 - 334
  • [5] Are SGLT2 inhibitors a targeted treatment for diabetic kidney disease?
    Kanda, Eiichiro
    Nangaku, Masaomi
    [J]. KIDNEY INTERNATIONAL, 2019, 96 (01) : 8 - 10
  • [6] Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    Ralph A. DeFronzo
    W. Brian Reeves
    Alaa S. Awad
    [J]. Nature Reviews Nephrology, 2021, 17 : 319 - 334
  • [7] Combination therapy with SGLT2 inhibitors for diabetic kidney disease
    Cai, Yuwen
    Liu, Xin
    Xu, Gaosi
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
  • [8] SGLT2 inhibitors in non-diabetic kidney disease
    Tesar, Vladimir
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (02): : 105 - 107
  • [9] SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
    Podesta, Manuel Alfredo
    Sabiu, Gianmarco
    Galassi, Andrea
    Ciceri, Paola
    Cozzolino, Mario
    [J]. BIOMEDICINES, 2023, 11 (02)
  • [10] Are SGLT2 Inhibitors Safe and Effective in Advanced Diabetic Kidney Disease?
    Zoungas, Sophia
    Polkinghorne, Kevan R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (12): : 1694 - 1695
12345